Rhogam Ultra-Filtered Plus
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Rhogam Ultra-Filtered Plus?
Rhogam Ultra-Filtered Plus is a brand name for a prescription medication called Rho D Immune Globulin (Human). It is used as a treatment to prevent complications in certain situations during pregnancy. This medication is specifically designed for women who have Rh-negative blood type and are pregnant with a baby who has Rh-positive blood type. In these cases, if fetal blood mixes with the mother's blood, it can trigger an immune response, leading to the mother's immune system producing antibodies against the Rh-positive blood cells in the baby. This can cause serious complications in subsequent pregnancies. Rhogam Ultra-Filtered Plus works by providing a dose of antibodies that target and neutralize any Rh-positive blood cells that might have entered the mother's bloodstream during pregnancy. This helps to prevent the mother's immune system from producing its own antibodies against the baby's blood cells and reduces the risk of complications. It's important to note that Rhogam Ultra-Filtered Plus should only be administered under the supervision of a healthcare professional and according to the prescribed dosage. Like any medication, it may have potential side effects, although they are generally rare and mild. Common side effects may include injection site reactions, shortness of breath, and headache. If you have any concerns or questions about its usage or potential side effects, it is best to consult with your healthcare provider.
How to use Rhogam Ultra-Filtered Plus?
Rhogam Ultra-Filtered Plus, also known as Rho D Immune Globulin (Human), is a prescription medication used to prevent complications in pregnancies where there is an Rh incompatibility between the mother and the fetus. It is typically given to Rh-negative mothers who are carrying Rh-positive babies. The administration of Rhogam Ultra-Filtered Plus is typically done by a healthcare professional. The medication is given via an intramuscular injection, usually in the deltoid muscle of the arm or the upper outer quadrant of the buttock. The dosage and frequency of the injections will be determined by the healthcare provider based on individual circumstances. It's important to follow your healthcare provider's instructions precisely when using Rhogam Ultra-Filtered Plus. The injection is usually given around the 28th week of pregnancy, and a second dose may be required within 72 hours after delivery if the baby is found to be Rh-positive. Rhogam Ultra-Filtered Plus should also be administered following any events that could mix the mother's and baby's blood, such as miscarriage, induced abortion, or any procedures that could cause bleeding. As with any medication, there may be potential side effects or risks associated with the use of Rhogam Ultra-Filtered Plus. It is crucial to discuss these with your healthcare provider to ensure proper understanding and to address any concerns.
Rhogam Ultra-Filtered Plus, also known as Rho D Immune Globulin (Human), is a medication indicated for Rh-negative women who are pregnant or have recently given birth to an Rh-positive baby. It is used to prevent the immune system from producing antibodies that can harm future pregnancies. There are several warnings associated with the use of Rhogam Ultra-Filtered Plus. These include: 1. Allergic reactions: Some individuals may experience allergic reactions to Rhogam Ultra-Filtered Plus or its components. It is important to inform the healthcare provider of any known allergies before using this medication. 2. Blood clotting disorders: Rhogam Ultra-Filtered Plus may increase the risk of blood clotting disorders, especially in patients with a history of such disorders. Prior medical history should be shared with the healthcare provider to assess the risks and benefits of using this medication. 3. Transfusion-related acute lung injury (TRALI): In rare cases, Rhogam Ultra-Filtered Plus may cause a severe reaction called transfusion-related acute lung injury (TRALI). This can lead to breathing difficulties and require immediate medical attention. 4. Hemolytic anemia: Rhogam Ultra-Filtered Plus may rarely cause a condition called hemolytic anemia, which is the breakdown of red blood cells. Symptoms may include fatigue, weakness, and jaundice. Prompt medical attention is necessary if such symptoms occur. It is important to discuss these warnings and any other concerns with a healthcare provider before using Rhogam Ultra-Filtered Plus. They can provide personalized guidance based on the individual's medical history and needs.
Before taking Rhogam Ultra-Filtered Plus (or its generic variant Rho D Immune Globulin), there are certain warnings and precautions to consider. These include: 1. Allergy or Sensitivity: If you have a known allergy or sensitivity to human immune globulin products or any of the components in Rhogam Ultra-Filtered Plus, it is important to inform your healthcare provider. Allergic reactions can range from mild to severe, so it is crucial to avoid this medication if you are allergic to any of its ingredients. 2. Hemolytic Anemia: Some individuals may have a condition called hemolytic anemia, where their body's immune system attacks and destroys red blood cells. It is important to discuss this condition with your healthcare provider, as Rhogam Ultra-Filtered Plus may not be suitable for individuals with this condition. 3. Blood Group: Rhogam Ultra-Filtered Plus is specifically used to prevent Rh(D) sensitization in Rh(D)-negative individuals who are exposed to Rh(D)-positive blood. It is essential to confirm your blood type and whether you are Rh(D)-negative before receiving Rhogam Ultra-Filtered Plus. 4. Administration Timing: Rhogam Ultra-Filtered Plus is typically given to Rh(D)-negative pregnant women around 28 weeks of gestation and within 72 hours after delivery if the baby is Rh(D)-positive. It is important to adhere to the recommended administration schedule and consult with your healthcare provider regarding the appropriate timing. 5. Transmission of Infectious Agents: As with any blood-derived products, there is a small risk of transmitting infectious agents, such as viruses, through Rhogam Ultra-Filtered Plus. However, extensive screening and manufacturing processes are in place to minimize this risk. 6. Side Effects: Like any medication, Rhogam Ultra-Filtered Plus can potentially cause side effects. Common side effects may include local injection site reactions (pain, swelling, redness), fever, headache, and body aches. It is important to report any unusual or severe reactions to your healthcare provider. It is crucial to discuss your medical history, allergies, and any other medications or supplements you are taking with your healthcare provider before receiving Rhogam Ultra-Filtered Plus. This will help ensure its safe and effective use for the prevention of Rh(D) sensitization.
RhoGAM Ultra-Filtered Plus, also known by its generic name Rho D Immune Globulin (Human), is a medication used during pregnancy to prevent complications related to Rh incompatibility. Rhogam is typically given to Rh-negative women who are at risk of developing Rh antibodies after exposure to Rh-positive blood, such as during pregnancy or after a miscarriage or blood transfusion. Although Rhogam is generally safe, there can be some potential side effects, as with any medication. These side effects are usually mild and temporary. Common side effects may include pain, redness, or swelling at the injection site. In rare cases, serious allergic reactions can occur. Signs of an allergic reaction may include hives, itching, difficulty breathing, and swelling of the face, lips, tongue, or throat. Seek immediate medical attention if you experience any of these symptoms. It's important to discuss any concerns or potential side effects with your healthcare provider before receiving Rhogam Ultra-Filtered Plus. They can provide you with personalized advice and guidance based on your specific medical history and circumstances.
Rhogam Ultra-Filtered Plus, which is a trademark name for Rho D Immune Globulin (Human), contains the active ingredient Rho(D) immune globulin. This immunoglobulin is derived from donated human plasma and is used for the prevention of hemolytic disease of the newborn (HDN) in certain situations. In addition to the active ingredient, Rhogam Ultra-Filtered Plus may also contain inactive ingredients such as sugars, stabilizers, and preservatives. These ingredients help to maintain the stability and effectiveness of the medication. It's worth mentioning that before using any medication, it is essential to consult with a healthcare professional or read the package insert for a comprehensive list of ingredients, as formulations and inactive ingredients can vary between different brands or manufacturers.
Rhogam Ultra-Filtered Plus, or Rho D Immune Globulin (Human), should be stored in a controlled temperature setting, typically between 2-8 degrees Celsius (36-46 degrees Fahrenheit). It is important to keep the medication refrigerated to maintain its effectiveness. During storage, it is crucial to protect the medication from light and freezing temperatures. The vials should be stored in the original packaging to shield them from direct exposure to light. Freezing the medication can cause damage and make it less effective or even ineffective. It's important to note that once the medication has been opened or reconstituted, it should be used immediately or discarded following the instructions provided by the healthcare provider or pharmacist. Do not store any unused portions for future use. Always check the expiration date on the packaging and do not use the medication if it has expired. If you have any concerns or questions about proper storage, it is best to consult with your healthcare provider or pharmacist for specific instructions related to Rhogam Ultra-Filtered Plus or Rho D Immune Globulin (Human).